Brasília – Between January and October 20 2025, Brazil saw a 61.4% increase in cases and a 64.6% rise in deaths caused by the bronchiolitis-triggering Respiratory Syncytial Virus (RSV) compared with the same period in 2024, according to data from the Ministry of Health. The rise is attributed in part to this year’s prolonged winter and higher virus transmission in children under two years of age.

Health specialists warned that the elevated burden places significant pressure on paediatric services and hospital-beds, especially in regions already facing resource shortages. They emphasize the need to expand access to preventive measures—including new RSV-vaccines for pregnant women and infants—and strengthen primary care for early diagnosis and intervention.

Source: Folha de S.Paulo

Want to explore this and other key issues in Brazil’s health system?
Contact us at pharmabrnews@gmail.com